RT Journal Article SR Electronic T1 Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer JF Journal of Medical Genetics JO J Med Genet FD BMJ Publishing Group Ltd SP 498 OP 502 DO 10.1136/jmedgenet-2015-103076 VO 52 IS 7 A1 Castillejo, Adela A1 Hernández-Illán, Eva A1 Rodriguez-Soler, María A1 Pérez-Carbonell, Lucía A1 Egoavil, Cecilia A1 Barberá, Victor M A1 Castillejo, María-Isabel A1 Guarinos, Carla A1 Martínez-de-Dueñas, Eduardo A1 Juan, María-Jose A1 Sánchez-Heras, Ana-Beatriz A1 García-Casado, Zaida A1 Ruiz-Ponte, Clara A1 Brea-Fernández, Alejandro A1 Juárez, Miriam A1 Bujanda, Luis A1 Clofent, Juan A1 Llor, Xavier A1 Andreu, Montserrat A1 Castells, Antoni A1 Carracedo, Angel A1 Alenda, Cristina A1 Payá, Artemio A1 Jover, Rodrigo A1 Soto, José-Luis YR 2015 UL http://jmg.bmj.com/content/52/7/498.abstract AB Background The prevalence of MLH1 constitutional epimutations in the general population is unknown. We sought to analyse the prevalence of MLH1 constitutional epimutations in unselected and selected series of patients with colorectal cancer (CRC).Methods Patients with diagnoses of CRC (n=2123) were included in the unselected group. For comparison, a group of 847 selected patients with CRC who fulfilled the revised Bethesda guidelines (rBG) were also included. Somatic and constitutional MLH1 methylation was assayed via methylation-specific multiplex ligation-dependent probe amplification of cases lacking MLH1 expression. Germline alterations in mismatch-repair (MMR) genes were assessed via Sanger sequencing and methylation-specific multiplex ligation-dependent probe amplification.Results Loss of MLH1 expression occurred in 5.5% of the unselected series and 12.5% of the selected series (p<0.0001). No constitutional epimutations in MLH1 were detected in the unselected population (0/62); five cases from the selected series were positive for MLH1 epimutations (15.6%, 5/32; p=0.004).Conclusions Our results suggest a negligible prevalence of MLH1 constitutional epimutations in unselected cases of CRC. Therefore, MLH1 constitutional epimutation analysis should be conducted only for patients who fulfil the rBG and who lack MLH1 expression with methylated MLH1.